Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Dr Reddy's Laboratories has introduced Levofloxacin tablets (250 mg, 500 mg and 750 mg) in the US market.
Subscribe to our email newsletter
The launching of the product follows the US Food and Drug Administration’s (FDA) approval of abbreviated new drug application (ANDA) for Levofloxacin tablets.
According to the company, Levofloxacin tablets (250 mg, 500 mg and 750 mg) are generic equivalent to Levaquin tablets.
Dr Reddy‘s Levofloxacin tablets 250 mg and 500 mg strengths are available in 50 count bottles and the 750 mg strength is available in 30 count bottles.